SV2A and schizophrenia: Therefore, we conducted a multimodal [11C]UCB-J PET and 1H-MRS imaging study to test the relationship between the synaptic terminal marker SV2A and glutamate levels in unmedicated patients with schizophrenia within the first episodes of psychosis.